United States· US:0220-5161_0a35df43-5bf6-c58f-e063-6294a90aa4e0
UVA URSI
A medicinal product containing arctostaphylos uva-ursi leaf, registered in United States by Boiron.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ARCTOSTAPHYLOS UVA-URSI LEAF
- Manufacturer
- Boiron
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1102205161416 [hp_C] in 1 TUBE (0220-5161-41)
- ndc110220-5161-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Arctostaphylos uva-ursi leaf in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyArctuvanKlinge Pharma Gmbh
- PolandCystinolSchaper & Bruemmer GmbH & Co. KG
- NetherlandsLyngonia, filmomhulde tabletFlorealis ehf.
- SwitzerlandSidroga Bärentraubenblätter, ArzneiteeUriach Switzerland AG
- IcelandLyngoniaFlorealis ehf.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Uroinfekt Blasenentzündung
- Germany · Arctuvan, Bärentraubenblätter zur Anwendung Bei Erwachsenen Und Kindern Ab 12 Jahren Sidroga
- Denmark · Lyngonia
- Spain · Rotercysti
- Finland · Lyngonia
- France · Arkogelules
- Hungary · Urovatin
- Iceland · Lyngonia
- Italy · Roteruti
- Luxembourg · Rotieruva-Ursi
- Netherlands · Lyngonia
- Norway · Lyngonia
- Poland · Liść Mącznicy
- Sweden · Lyngonia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7974c96-3692-4931-84d9-e0ff445e4a7d GET /v1/drugs/b7974c96-3692-4931-84d9-e0ff445e4a7d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "6",
"substance": "ARCTOSTAPHYLOS UVA-URSI LEAF",
"productndc": "0220-5161",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/6[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about arctostaphylos uva-ursi leaf.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.